Charles F. Wagner Jr

Insider Reports History

Entity
Individual
Location
C/O Millipore Corp, Billerica, Massachusetts
Signature
/s/ Erica Farrell, by Power of Attorney dated September 20, 2023
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles F. Wagner Jr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA EVP & Chief Financial Officer Common Stock 47,137 $21.7 M $460.00 Jun 3, 2024 Direct
TJX COMPANIES INC /DE/ Director Deferred Stock Units 1,675 $176 K $105.10 Jun 4, 2024 Direct

Insider Reports Filed by Charles F. Wagner Jr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TJX TJX COMPANIES INC /DE/ Jun 4, 2024 4 0 4 Jun 6, 2024 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Jun 3, 2024 1 -1,495,000 4 Jun 5, 2024 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA May 28, 2024 1 -1,478,068 4 May 30, 2024 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 23, 2024 1 -1,428,793 4 Feb 27, 2024 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 16, 2024 2 -2,772,708 4 Feb 21, 2024 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 9, 2024 1 -1,102,083 4 Feb 13, 2024 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 6, 2024 3 0 4 Feb 8, 2024 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Jan 2, 2024 1 -1,215,000 4 Jan 4, 2024 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 20, 2023 1 -1,049,640 4 Nov 21, 2023 EVP & Chief Financial Officer
TJX TJX COMPANIES INC /DE/ Sep 20, 2023 2 0 4 Sep 22, 2023 Director
TJX TJX COMPANIES INC /DE/ Sep 20, 2023 0 0 3 Sep 22, 2023 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Mar 24, 2023 1 -539,912 4 Mar 28, 2023 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Mar 17, 2023 6 -592,786 4 Mar 21, 2023 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Mar 10, 2023 14 -1,388,054 4 Mar 14, 2023 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2023 1 -956,409 4 Feb 28, 2023 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2023 1 -1,098,188 4 Feb 22, 2023 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2023 2 -2,285,665 4 Feb 14, 2023 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2023 3 0 4 Feb 3, 2023 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA May 2, 2022 7 -88,778 4 May 4, 2022 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 29, 2022 1 -151,065 4 May 3, 2022 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 1, 2022 5 -683,602 4 Apr 5, 2022 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Mar 17, 2022 2 -793,218 4 Mar 21, 2022 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2022 1 -498,786 4 Feb 28, 2022 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2022 1 -799,602 4 Feb 22, 2022 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2022 1 -578,659 4 Feb 14, 2022 EVP & Chief Financial Officer
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2022 4 -736,206 4 Feb 3, 2022 EVP & Chief Financial Officer